LGDN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ligand Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 250 EUR -0.79% Market Closed

Market Cap: €4.5B

L	Ligand Pharmaceuticals Inc F:LGDN	US
H	Harmony Gold Mining Company Ltd JSE:HAR	ZA
	Sturm Ruger & Company Inc NYSE:RGR	US
	Taiwan Semiconductor Manufacturing Co Ltd NYSE:TSM	TW
S	Six Flags Entertainment Corp XBER:6FE	US
D	Dillard's Inc SWB:DL7A	US
B	Bureau Veritas SA F:4BV	FR

Profitability Summary

Ligand Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

92%

Gross Margin is Increasing

74% > 95%

Exceptional Operating Margin

35%

Low 3Y Average Operating Margin

Operating Margin is Increasing

23% > 35%

Exceptional Net Margin

56%

Sustainable 3Y Average Net Margin

19%

Net Margin is Increasing

17% > 56%

Exceptional Free Cash Flow Margin

45%

Strong 3Y Average Free Cash Flow Margin

20%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.